Key Highlights from PetIQ's Special Stockholder Meeting
PetIQ, Inc. has made significant strides in its journey as a leading pet health and wellness company. Recently, during a virtual Special Meeting of Stockholders, approximately 80% of the outstanding shares voted to approve a crucial merger agreement. This agreement paves the way for Bansk Group to acquire all of PetIQ's outstanding shares for $31.00 each, totaling around $1.5 billion in cash.
Company's Vision for the Future
Cord Christensen, the Founder and CEO of PetIQ, expressed enthusiasm regarding the stockholders' approval of this transformative deal. He emphasized that this merger is not just a financial transaction but an important milestone that aligns with their mission of providing accessible pet healthcare. The anticipated closing date for the merger is set for a few days from now, making it an exciting period for the company.
Impact of the Merger on PetIQ's Operations
Once the merger is finalized, PetIQ will cease to be listed on the NASDAQ stock exchange, transitioning into a privately held entity. Despite this change, PetIQ's dedicated executive team plans to continue the company's operations independently. The commitment to delivering high-quality pet healthcare products and services remains a top priority
PetIQ's Commitment to Pet Owners
With an impressive portfolio of pet medication and wellness products, PetIQ has built a reputation for innovation in the pet health sector. The company's approach combines retail and e-commerce strategies to make health solutions available to pet owners. It manufactures and distributes products from state-of-the-art facilities located across several states, ensuring a steady supply of both over-the-counter and prescription medications.
A Closer Look at PetIQ's Services
In addition to their product offerings, PetIQ provides veterinary services through mobile community clinics and wellness centers. Over 2,600 locations operate across numerous states, making professional pet care easily accessible to countless pet owners. This extensive network underscores PetIQ's commitment to ensuring pets receive the best possible care.
Investor Relations and Contacts
For more detailed updates regarding the merger and PetIQ's future endeavors, interested parties can reach out to Investor Relations. The primary contact for inquiries is Katie Turner, available at 208.513.1513. Additionally, for media-related questions, you can connect with Kara Schafer at 407.929.6727.
Frequently Asked Questions
What was approved at the Special Meeting?
Stockholders voted to approve a merger agreement between PetIQ and Bansk Group, which will allow Bansk Group to acquire PetIQ.
What is the merger deal value?
The merger deal is valued at approximately $1.5 billion, with a purchase price of $31.00 per share.
How will the merger affect PetIQ's operations?
Post-merger, PetIQ will no longer be publicly traded and will continue to operate independently.
Who should I contact for investor relations?
Katie Turner is the Investor Relations contact at PetIQ, reachable at 208.513.1513.
What services does PetIQ offer?
PetIQ provides a range of pet medications, health products, and veterinary services through mobile clinics and wellness centers.
